Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity

LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix

(2010) Håkan Hedman et al.   ACTA ONCOLOGICA

Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway

(2009) Kim-Son H. Nguyen et al.   Clinical Lung Cancer

EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma

(2009) Kazuhiro Kaneko   Frontiers in Bioscience-Landmark

Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival

(2009) Camilla Holmlund et al.   NEUROPATHOLOGY

Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF

(2008) F. Ledda et al.   JOURNAL OF NEUROSCIENCE

LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII

(2008) M A Stutz et al.   ONCOGENE

LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking

(2007) A.K. LINDSTRÖM et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER